Patent 8088593 was granted and assigned to Theranos on January, 2012 by the United States Patent and Trademark Office.
The present invention provides devices and systems for use at the point of care. The methods devices of the invention are directed toward automatic detection of analytes in a bodily fluid. The components of the device are modular to allow for flexibility and robustness of use with the disclosed methods for a variety of medical applications.